Detalhe da pesquisa
1.
Study protocol of an open-label, single arm phase II trial investigating the efficacy and safety of Trifluridine/Tipiracil combined with irinotecan as a second line therapy in patients with cholangiocarcinoma (TRITICC).
BMC Cancer
; 23(1): 470, 2023 May 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37217885
2.
Current Trends in Inpatient Care and In-Hospital Mortality of Cholangiocarcinoma in Germany: A Systematic Analysis between 2010 and 2019.
Cancers (Basel)
; 14(16)2022 Aug 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36011031